Abstract
Current evidence shows that thioridazine (THZ) is ready for global clinical evaluation, while some of its derivatives and other efflux pump inhibitors reach the end stage of preclinical evaluation. In this paper, a clinical trial plan is described that investigates the antituberculosis potency, the safety profile and the role of THZ and/or its derivatives in the treatment of TB in humans, both in patients infected with drug sensitive strains as in patients infected with multi or extensive drug resistant strains of Mycobacterium tuberculosis and some of the patents related to thioridazine are also discussed.
Keywords: Global clinical trials, therapy of XDR-TB, thioridazine, TRIAL PLAN, rifampicin, THZ, The OBT Design, Toxicity Profile, Antituberculosis Antibiotics, Compassionate Use
Recent Patents on Anti-Infective Drug Discovery
Title: Global Clinical Trials for the Treatment of TB with Thioridazine
Volume: 6 Issue: 2
Author(s): Martin J. Boeree
Affiliation:
Keywords: Global clinical trials, therapy of XDR-TB, thioridazine, TRIAL PLAN, rifampicin, THZ, The OBT Design, Toxicity Profile, Antituberculosis Antibiotics, Compassionate Use
Abstract: Current evidence shows that thioridazine (THZ) is ready for global clinical evaluation, while some of its derivatives and other efflux pump inhibitors reach the end stage of preclinical evaluation. In this paper, a clinical trial plan is described that investigates the antituberculosis potency, the safety profile and the role of THZ and/or its derivatives in the treatment of TB in humans, both in patients infected with drug sensitive strains as in patients infected with multi or extensive drug resistant strains of Mycobacterium tuberculosis and some of the patents related to thioridazine are also discussed.
Export Options
About this article
Cite this article as:
J. Boeree Martin, Global Clinical Trials for the Treatment of TB with Thioridazine, Recent Patents on Anti-Infective Drug Discovery 2011; 6 (2) . https://dx.doi.org/10.2174/157489111796064533
DOI https://dx.doi.org/10.2174/157489111796064533 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design Preparation and Antitubercular Activities of Palindromic Hydrazinecarbothioamides and Carbonothioic Dihydrazides
Letters in Drug Design & Discovery Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence
Medicinal Chemistry Hydrogel-clay Nanocomposites as Carriers for Controlled Release
Current Medicinal Chemistry Optimization of Supercritical Fluid Extraction for <i>Mariposa Christia Vespertilionis</i> Leaves Towards Yield by Using Response Surface Methodology
Recent Innovations in Chemical Engineering Long-term Etanercept Therapy Favors Weight Gain and Ameliorates Cachexia in Rheumatoid Arthritis Patients: Roles of Gut Hormones and Leptin
Current Pharmaceutical Design Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science Lymphadenopathy as a Prodrome for Systemic Lupus Erythematous
Current Rheumatology Reviews Linezolid Induced Adverse Drug Reactions - An Update
Current Drug Metabolism Synthesis, Molecular Docking, in vitro Antiproliferative and Antioxidant Activity of Novel Pyrrolidinyl-Carbazole Derivatives
Current Organic Synthesis Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis
Current Drug Delivery Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact
Current Immunology Reviews (Discontinued) A Pharmacological Review of Five Widely Used Traditional Medicinal Plants for Sedative-Hypnotic Effects in Bangladesh
Current Traditional Medicine Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Review of QSAR studies to Discover New Drug-like Compounds Actives Against Leishmaniasis and Trypanosomiasis
Current Topics in Medicinal Chemistry Modulation of Neutrophil Development and Homeostasis
Current Molecular Medicine Drug Resistance of Antitubercular Agents at the Genetic Level in Mycobacterium Species: A Road Map to Drug Development for Counteracting the Resistance
Mini-Reviews in Organic Chemistry Enhanced Production of Cholesterol Oxidase from Bacillus sp. COX-T<sub>3</sub> in a Biphasic System
Current Biotechnology Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine Migration and Function of Th17 Cells
Inflammation & Allergy - Drug Targets (Discontinued)